Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40217
Submission : 2024-07-22
Status :
Type : IV
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
43
PharmaCompass offers a list of Salcaprozate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier.
A sodium 8-(2-hydroxybenzamido)octanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of sodium 8-(2-hydroxybenzamido)octanoate, including repackagers and relabelers. The FDA regulates sodium 8-(2-hydroxybenzamido)octanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. sodium 8-(2-hydroxybenzamido)octanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of sodium 8-(2-hydroxybenzamido)octanoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A sodium 8-(2-hydroxybenzamido)octanoate supplier is an individual or a company that provides sodium 8-(2-hydroxybenzamido)octanoate active pharmaceutical ingredient (API) or sodium 8-(2-hydroxybenzamido)octanoate finished formulations upon request. The sodium 8-(2-hydroxybenzamido)octanoate suppliers may include sodium 8-(2-hydroxybenzamido)octanoate API manufacturers, exporters, distributors and traders.
click here to find a list of sodium 8-(2-hydroxybenzamido)octanoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A sodium 8-(2-hydroxybenzamido)octanoate DMF (Drug Master File) is a document detailing the whole manufacturing process of sodium 8-(2-hydroxybenzamido)octanoate active pharmaceutical ingredient (API) in detail. Different forms of sodium 8-(2-hydroxybenzamido)octanoate DMFs exist exist since differing nations have different regulations, such as sodium 8-(2-hydroxybenzamido)octanoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A sodium 8-(2-hydroxybenzamido)octanoate DMF submitted to regulatory agencies in the US is known as a USDMF. sodium 8-(2-hydroxybenzamido)octanoate USDMF includes data on sodium 8-(2-hydroxybenzamido)octanoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The sodium 8-(2-hydroxybenzamido)octanoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of sodium 8-(2-hydroxybenzamido)octanoate suppliers with USDMF on PharmaCompass.
A sodium 8-(2-hydroxybenzamido)octanoate written confirmation (sodium 8-(2-hydroxybenzamido)octanoate WC) is an official document issued by a regulatory agency to a sodium 8-(2-hydroxybenzamido)octanoate manufacturer, verifying that the manufacturing facility of a sodium 8-(2-hydroxybenzamido)octanoate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting sodium 8-(2-hydroxybenzamido)octanoate APIs or sodium 8-(2-hydroxybenzamido)octanoate finished pharmaceutical products to another nation, regulatory agencies frequently require a sodium 8-(2-hydroxybenzamido)octanoate WC (written confirmation) as part of the regulatory process.
click here to find a list of sodium 8-(2-hydroxybenzamido)octanoate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing sodium 8-(2-hydroxybenzamido)octanoate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for sodium 8-(2-hydroxybenzamido)octanoate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture sodium 8-(2-hydroxybenzamido)octanoate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain sodium 8-(2-hydroxybenzamido)octanoate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a sodium 8-(2-hydroxybenzamido)octanoate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of sodium 8-(2-hydroxybenzamido)octanoate suppliers with NDC on PharmaCompass.
sodium 8-(2-hydroxybenzamido)octanoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of sodium 8-(2-hydroxybenzamido)octanoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right sodium 8-(2-hydroxybenzamido)octanoate GMP manufacturer or sodium 8-(2-hydroxybenzamido)octanoate GMP API supplier for your needs.
A sodium 8-(2-hydroxybenzamido)octanoate CoA (Certificate of Analysis) is a formal document that attests to sodium 8-(2-hydroxybenzamido)octanoate's compliance with sodium 8-(2-hydroxybenzamido)octanoate specifications and serves as a tool for batch-level quality control.
sodium 8-(2-hydroxybenzamido)octanoate CoA mostly includes findings from lab analyses of a specific batch. For each sodium 8-(2-hydroxybenzamido)octanoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
sodium 8-(2-hydroxybenzamido)octanoate may be tested according to a variety of international standards, such as European Pharmacopoeia (sodium 8-(2-hydroxybenzamido)octanoate EP), sodium 8-(2-hydroxybenzamido)octanoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (sodium 8-(2-hydroxybenzamido)octanoate USP).
